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xcessive accumulation of amyloid 
 
 
 
-peptide (A
 
 
 
)
plays an early and critical role in synapse and
neuronal loss in Alzheimer’s Disease (AD). Increased
oxidative stress is one of the mechanisms whereby A
 
 
 
induces neuronal death. Given the lessened susceptibility
to oxidative stress exhibited by mice lacking p66Shc, we
investigated the role of p66Shc in A
 
 
 
 toxicity. Treatment
of cells and primary neuronal cultures with A
 
 
 
 caused
apoptotic death and induced p66Shc phosphorylation at
Ser36. Ectopic expression of a dominant-negative SEK1
mutant or chemical JNK inhibition reduced A
 
 
 
-induced
E
 
JNK activation and p66Shc phosphorylation (Ser36),
suggesting that JNK phosphorylates p66Shc. A
 
 
 
 induced
the phosphorylation and hence inactivation of forkhead
transcription factors in a p66Shc-dependent manner.
Ectopic expression of p66ShcS36A or antioxidant treat-
ment protected cells against A
 
 
 
-induced death and reduced
forkhead phosphorylation, suggesting that p66Shc phos-
phorylation critically inﬂuences the redox regulation of
forkhead proteins and underlies A
 
 
 
 toxicity. These ﬁnd-
ings underscore the potential usefulness of JNK, p66Shc,
and forkhead proteins as therapeutic targets for AD.
 
Introduction
 
Alzheimer’s Disease (AD) is a neurodegenerative disease that
causes progressive cognitive and behavioral deterioration.
Although research on AD is extensive, the etiology of the disease
is not completely understood. A central hypothesis in AD re-
search is that the accumulation of amyloid 
 
 
 
-peptide (A
 
 
 
), which
is derived from proteolytic processing of amyloid precursor pro-
tein, is an early and critical event leading to synapse and neuronal
cell loss (Iversen et al., 1995; Selkoe, 2001). Increased oxidative
stress has been proposed to play an important role in A
 
 
 
-induced
neuronal death in AD because reactive oxygen species (ROS)
and oxidized lipids and proteins increase and accumulate in AD
brain (Behl et al., 1994; Selkoe, 2001; Butterfield et al., 2002;
Butterfield and Bush, 2004; Huang et al., 2004). In vitro studies
have shown that complexes resulting from the association of A
 
 
 
with metals (Fe, Cu, and Zn) exhibit metalloenzyme-like activi-
ties leading to the production of neurotoxic H
 
2
 
O
 
2
 
 (Huang et al.,
1999a; Opazo et al., 2002). However, the signaling mechanisms
whereby A
 
 
 
 induces oxidative cell death remain unclear.
A heightened resistance to oxidative stress has been
shown to increase longevity in 
 
Caenorhabditis elegans
 
 and
mice (Lin et al., 1997; Migliaccio et al., 1999). Mice lacking
the adaptor protein p66Shc live 30% longer than control ani-
mals, and cells derived from these mice are resistant to ROS-
induced apoptosis (Migliaccio et al., 1999). p66Shc plays an
important role in signal transduction from tyrosine kinases
to Ras protooncogenes. The three mammalian ShcA iso-
forms (p46, p52, and p66) share structural features including a
COOH-terminal Src homology 2 domain, a proline- and gly-
cine-rich region, a collagen-homologous region 1, and an
NH
 
2
 
-terminal phosphotyrosine-binding domain (Pelicci et al.,
1992; Luzi et al., 2000). In addition, there is a unique colla-
gen-homologous region 2 domain at the NH
 
2
 
 terminus of
the p66Shc isoform containing a serine phosphorylation site
(Ser36). It is well established that Shc proteins are phosphory-
lated at tyrosine residues in response to stimulation by a variety
of growth factors and cytokines (Pelicci et al., 1992; Rozakis-
Adcock et al., 1992; Cutler et al., 1993; Pronk et al., 1993; Ruff-
Jamison et al., 1993). The p46 and p52 isoforms transmit signals
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from receptor tyrosine kinases to the Ras–MAPK pathway by
forming a stable complex involving Grb2 and a Ras exchange
factor, SOS (Son of Sevenless; Pelicci et al., 1992; Egan et al.,
1993; Skolnik et al., 1993; Aronheim et al., 1994; Kavanaugh
and Williams, 1994; Ohmichi et al., 1994). However, p66Shc
appears to be functionally different from the p46 and p52 iso-
forms. Unlike the other isoforms, p66Shc undergoes phosphory-
lation mainly at Ser36 after exposure to oxidative stress such as
UV light or H
 
2
 
O
 
2
 
 (Kao et al., 1997; Migliaccio et al., 1999;
Yang and Horwitz, 2000; Le et al., 2001; Nemoto and Finkel,
2002), although p66Shc is also transiently phosphorylated at ty-
rosine residues in response to growth factor stimulation (Bonfini
et al., 1996; Migliaccio et al., 1997). Phosphorylation at Ser36 is
required for conferring increased susceptibility to oxidative
stress and is critical for the cell death response elicited by oxida-
tive damage (Skulachev, 2000). Therefore, prevention of this
phosphorylation may have a therapeutic impact on diseases that
are associated with oxidative damage.
Forkhead transcription factors (FKHs) are a large family
of gene products expressed in species ranging from yeast to
human, all of which have a domain with sequence similarly to
 
Drosophila 
 
forkhead protein. A forkhead subfamily member,
DAF-16 in 
 
C. elegans
 
, functions in insulin signaling path-
ways and influences longevity (Lin et al., 1997, 2001; Ogg et
al., 1997; Accili and Arden, 2004; Giannakou et al., 2004;
Hwangbo et al., 2004). Previous studies have demonstrated
that for each of the three DAF-16 vertebrate homologues,
FKHR (FOXO1), FKHR-L1 (FOXO3a), and AFX (FOXO4),
phosphorylation results in the retention of the protein in the
cytosol and, hence, a reduction in forkhead-dependent tran-
scriptional activity (Biggs et al., 1999; Brunet et al., 1999;
Kops et al., 1999; Takaishi et al., 1999; Tang et al., 1999;
Burgering and Kops, 2002). Subsequent studies have demon-
strated the roles of FKHRL1, FKHR, and AFX in the insulin
response, the oxidative stress response, and the growth arrest/
apoptosis pathways (S. Guo et al., 1999; Medema et al., 2000;
Zheng et al., 2002; Brunet et al., 2004). Strikingly, recent pa-
pers show that p66Shc regulates intracellular oxidant levels in
mammalian cells and that ROS can negatively regulate fork-
head activity (Nemoto and Finkel, 2002; Trinei et al., 2002).
In contrast, activation of FKHs leads to transcriptional activa-
tion of the manganese superoxide dismutase (MnSOD) gene
and increases MnSOD mRNA and protein levels. Elevated
MnSOD levels cause a reduction of ROS and protection
against cell death (Nemoto and Finkel, 2002; Trinei et al.,
2002). The role of p66Shc and FKHs in A
 
 
 
-induced oxidative
damage in AD is unknown.
In this study, we test the hypothesis that A
 
 
 
 increases intra-
cellular ROS level, activates the p66Shc signaling pathway, and
negatively regulates FKH activity. We demonstrate that treatment
with A
 
 
 
 causes cell death and p66Shc phosphorylation at Ser36,
partially in a JNK-dependent manner. A
 
 
 
 induced the phosphory-
lation (inactivation) of forkhead FKHRL1 and FKHR transcrip-
tion factors in established cultures and in mouse primary neuronal
cultures. Cells that ectopically expressed p66ShcS36A or were
treated with antioxidants were protected against A
 
 
 
-induced death
and exhibited reduced forkhead phosphorylation. These findings
lend strong support to the notion that phosphorylation of Shc66
and forkhead protein play important roles in A
 
 
 
 toxicity in AD.
 
Results
 
A
 
 
 
 induces phosphorylation of p66Shc at 
serine 36
 
p66Shc is phosphorylated on serine/threonine residues in re-
sponse to cellular stress induced by treatment with UV, H
 
2
 
O
 
2
 
,
Figure 1. Treatment of A  induces the phosphorylation of p66Shc at Ser36
residues in SH-SY5Y cells. (A) SH-SY5Y and PC12 cells were treated with
30  M A 25-35 or A 35-25 for 24 h in serum-free media containing N2
supplements. Trypan blue exclusion was used to determine cell death. Data
are means   SEM for three separate experiments performed in duplicate. *,
P   0.05 versus untreated cells. (B) Western blot analysis showing phosphor-
ylated and total p66Shc in SH-SY5Y cells treated with 30  M A  for the
indicated times after a 16-h serum starvation period by using a specific
anti–phospho-p66Shc (Ser36) antibody (top) and an anti-Shc polyclonal an-
tibody (bottom). The blots are representative of three separate experiments.
(C) At 7 DIV, cultures were treated with A  for 24 h, whereupon representa-
tive photographs were taken to illustrate the changes in cell morphology. (D)
At 7 DIV, cells treated with A 25-35 or A 35-25 for 24 h and Hoechst
33342 labeling were used to determine cell death. Data are the means  
SEM of three separate experiments performed in duplicate. (E) Western blot
analysis to detect p66Shc phosphorylation in 7 DIV cultures treated with 25
 M A  for the indicated times was performed by using a specific anti–phos-
pho-p66Shc (Ser36) antibody (top) and an anti-Shc polyclonal antibody
(bottom). The blots are representative of three separate experiments. (F) SH-
SY5Y cells treated with 30  M A  for 30 min after a 16-h serum starvation
period. The cells were harvested and the lysates were either treated with
PP2A1 or left untreated, and then sequentially blotted with a specific anti–
phospho-p66Shc (Ser36) antibody (top) and an anti-Shc polyclonal antibody
(bottom). The blots are representative of three separate experiments. 
P66SHC/FORKHEAD PROTEINS MEDIATE A
 
 
 
 TOXICITY • SMITH ET AL.
 
333
 
or Taxol (Kao et al., 1997; Migliaccio et al., 1999; Yang and
Horwitz, 2000; Le et al., 2001; Nemoto and Finkel, 2002), al-
though p66Shc also is transiently phosphorylated at tyrosine
residues in response to growth factor stimulation (Bonfini et
al., 1996; Migliaccio et al., 1997). Here, we set out to investi-
gate the role of p66Shc in A
 
 
 
 toxicity. Treatment of human
neuroblastoma SH-SY5Y and neuronal-like PC12 cells with 30
 
 
 
M A
 
 
 
 25-35 (hereafter A
 
 
 
) for 24 h caused cell death in both
cell lines, whereas 30 
 
 
 
M of the control peptide A
 
 
 
 35-25 had
no effect (Fig. 1 A). To determine whether or not p66Shc was
phosphorylated on Ser36 in response to A
 
 
 
, lysates of A
 
 
 
-
treated SH-SY5Y cells were analyzed by Western blotting us-
ing an antibody that specifically recognized phospho-p66Shc at
Ser36. A
 
 
 
 treatment of cells rapidly induced p66Shc phos-
phorylation at Ser36, which remained elevated for 15 h (Fig. 1
B, top), whereas A
 
 
 
 35-25 treatment of cells was without effect
(not depicted). In contrast, protein levels of p66, p52, and p46
isoforms were not affected (Fig. 1 B, bottom). We confirmed
these results by immunoprecipitating total Shc protein and
performing Western blot analysis using the Ser36 phospho-
p66Shc antibody (unpublished data). We also assessed the
phosphorylation of p66Shc by using mouse cortical neuronal
cultures at 7 d in vitro (DIV). A
 
 
 
 treatment of cultures caused
dose-dependent cell death (Fig. 1, C and D) and induced
p66Shc phosphorylation at Ser36, which remained elevated for
24 h (Fig. 1 E), whereas the response of A
 
 
 
 35-25–treated cul-
tures was comparable to that of untreated cultures. The phos-
phorylation of p66Shc was abolished by serine/threonine pro-
tein phosphatase 2A1 (PP2A1; Fig. 1 F), further confirming
that p66Shc is phosphorylated at Ser36 by A
 
 
 
.
 
Cells expressing dominant-negative 
p66ShcS36A are protected against A
 
 
 
 
toxicity
 
To investigate the functional consequences of the phosphory-
lation of p66Shc at Ser36 by A
 
 
 
, PC12 cells overexpress-
ing wild-type p66Shc (p66Shc) and a serine 36-to-alanine
(and therefore nonphosphorylatable) mutant of p66Shc
(p66ShcS36A; Fig. 2 A) were treated with A
 
 
 
 for 24 h. PC12
cells expressing p66Shc (clone A) were sensitive to A
 
 
 
, with
 
 
 
40% of cells dying as measured by Trypan blue exclusion
(Fig. 2 B). A Hoechst labeling assay revealed a fourfold in-
crease in apoptosis in A
 
 
 
-treated cells compared with un-
treated control cells (Fig. 2 C), whereas PC12 cells expressing
p66ShcS36A (clone a) were almost completely resistant to A
 
 
 
-
induced cell death (Fig. 2, B and C). Caspase-3 activity in
PC12 cells expressing p66Shc (clone A) increased significantly
after A
 
 
 
 treatment and remained unchanged in PC12 cells ex-
pressing p66ShcS36A (clone a) (Fig. 2 D). Two other clones of
p66Shc (clones B and C) exhibited sensitivities to A
 
 
 
 treat-
ment comparable to those of clone A, whereas two additional
clones of p66ShcS36A (clones b and c) displayed sensitivities
to A
 
 
 
 treatment comparable to those of clone a (Fig. 2 E). The
growth rates of all of the clones were the same as those of the
vector populations, supporting the notion that the differences in
sensitivity to A
 
 
 
 were indeed linked to the expression of
p66Shc, either wild type or mutant.
We further confirmed these results by cotransfecting a
GFP expression plasmid with the second plasmid, pcDNA3.1-
xpress, expressing either p66Shc or p66ShcS36A or lacking an
insert. 24 h after transfection, cells were treated for an addi-
tional 24 h with A
 
 
 
, and GFP-positive cells were counted using
fluorescence microscopy. The transfection efficiencies were
similar in all transfection groups (unpublished data). There
were significantly more GFP-positive cells in the p66ShcS36A-
transfected group than in groups transfected with either vector
or p66Shc (Fig. 3). These results support the view that p66Shc
is a crucial component in A
 
 
 
-induced cell death.
To further understand the protection engendered by
p66ShcS36A, intracellular ROS levels were measured by the re-
dox-sensitive fluorophore 2
 
 
 
,7
 
 
 
-dichlorofluorescein (DCF) diac-
etate (DCFDA). Nonfluorescent DCFDA is converted by oxida-
tion to the fluorescent molecular DCF. Under basal conditions,
the level of DCF was very low in vector control-transfected cells
Figure 2. Ectopic expression of dominant-negative p66ShcS36A protects
against A -induced PC12 cell death. (A) Western blot analysis of Shc
expression in PC12 cells stably transfected with vector, p66Shc (clones A,
B, and C), or p66ShcS36A (clones a, b, and c) was performed using an
anti-Shc antibody. rShc, recombinant Shc carrying the xpress-tag. (B and
C) PC12 populations ectopically expressing either p66Shc (clone A) or
p66ShcS36A (clone a) were treated with A  for 24 h in serum-free me-
dia containing N2 supplements. Cell death was measured by Trypan
blue exclusion (panel B) and Hoechst nuclear labeling (panel C). (D)
PC12  populations ectopically expressing either p66Shc (clone A) or
p66ShcS36A (clone a) were treated with A  for the indicated times in
serum-free media containing N2 supplements. The activity of caspase-3
in cell extracts was measured colorimetrically by cleavage of DEVD-p-
nitroanilide. The results are means   SEM from five independent experi-
ments. (E) PC12 populations ectopically expressing p66Shc (clones B and C)
or p66ShcS36A (clones b and c) were treated with 30  M A  for 24 h
in serum-free media containing N2 supplements, whereupon cell death
was measured by Trypan blue exclusion. Data are means   SEM for three
separate experiments performed in duplicate. 
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as well as in p66Shc- and p66ShcS36A-expressing cell lines
(unpublished data). However, when these cells were treated with
30 
 
 
 
M A
 
 
 
 25-35 for 4 h, the level of DCF was three- to fourfold
lower in p66ShcS36A-expressing cells compared with p66Shc-
expressing cells (Fig. 4). Previous papers had shown that A  in-
creased the levels of mitochondrial superoxide and peroxynitrite
in PC12 cells (Q. Guo et al., 1999), so we also measured cellular
superoxide production with hydroethidine (HE), which is con-
verted to ethidium when oxidized by superoxide (ethidium then
bends the DNA and is thereby trapped in the cell, accumulating
over time). The level of ethidium was two- to threefold lower in
p66ShcS36A-expressing cells compared with p66Shc-express-
ing cells after A  treatment for 12 h (Fig. 4 E). The dye dihy-
drorhodamine (DHR) was used to quantify the relative levels of
mitochondrial peroxynitrite. As shown in Fig. 4 F, 12 h after
treatment with 30  M A  25-35, the levels of DHR fluorescent
was about twofold lower in p66ShcS36A-expressing cells com-
pared with p66Shc-expressing cells. These results suggested that
p66Shc influenced A -induced intracellular ROS, superoxide
level, and mitochondrial ROS levels.
A -induced phosphorylation of p66Shc 
at Ser36 is partly dependent on JNK 
activation
JNK is a stress-activated protein kinase that plays an impor-
tant role in response to oxidative damage. Recently, we dem-
onstrated that activation of the JNK pathway by A  causes
cell death (Wei et al., 2002b). To investigate whether or not
A -induced JNK activation affects p66Shc phosphorylation
at serine 36, SH-SY5Y cells expressing either an insertless
vector (SYV) or a dominant-negative mutant of SEK1 (an up-
stream kinase of JNK) SEK-AL were treated with A  for the
indicated times. Lysates of A -treated cells were analyzed by
Western blotting with a specific antibody recognizing phos-
pho-p66Shc (Ser36). SYV-transfected cells showed p66Shc
phosphorylation at Ser36 between 15 to 90 min after stimula-
tion with 30  M A . In contrast, cells expressing SEK1-AL
exhibited 65% lower p66Shc phosphorylation at 15 min after
A  treatment (Fig. 5 A). To determine if this decreased
p66Shc phosphorylation correlated with suppression of A -
induced neuronal death, cell death was assessed by Trypan
blue exclusion (Fig. 5 B) after A  treatment of mutant SEK1-
Figure 3. Transient expression of dominant-negative p66ShcS36A protects
against A -induced SH-SY5Y cell death. (A) SH-SY5Y cells were cotrans-
fected with pcDNA3.1-GFP along with either vector pcDNA3.1-xpress,
pcDNA3.1-xpress-p66Shc, or pcDNA3.1-xpress-p66ShcS36A at 1:10
ratios for 24 h in 10% FBS DME media, and then incubated with 2% FBS-
containing DME and treated with 30  M A  for 24 h. GFP-positive cells
were counted by using fluorescence microscopy. Representative photo-
micrographs for each treatment group are shown: top panels, GFP signals;
bottom panels, cell morphology under light microscopy. (B) Quantitation
of data in A, representing the cell viability of each treatment group. A min-
imum of 1,000 cells were counted for each treatment group and the
percentage of GFP-positive cells relative to the total number of cells in six
random fields was calculated. Data are means   SEM for three separate
experiments performed in duplicate. *, P   0.05 versus untreated cells; #,
P   0.05 versus A -treated vector cells. Figure 4. Overexpression of p66ShcS36A lowers intracellular ROS,
superoxide level, and mitochondrial ROS levels. (A) Quantification of DCF
fluorescence in PC12 cells that were either left untreated or were treated
with 30  M A  using confocal microscopy and the METAMORPH image
analysis software. Representative DCF fluorescence after treatment with 30
 M A  for a 4-h time period in PC12 cells stably transfected with plasmids
ectopically expressing p66Shc (clone A; panel B) or p66ShcS36A (clone
a; panel C) under confocal photomicrography of DCFDA fluorescence.
These experiments were repeated three times with similar results. (D) Quan-
tification of DCF fluorescence in PC12 cells that were either left untreated
or treated with 30  M A  by using a CytoFluor Multi-well Plate Reader.
(E) Quantification of HE fluorescence in PC12 cells that were either left
untreated or treated with 30  M A  for 12 h. (F) Quantification of DHR
fluorescence in PC12 cells that were either left untreated or treated with 30
 M A  for 12 h. Data are means   SEM for three separate experiments.P66SHC/FORKHEAD PROTEINS MEDIATE A  TOXICITY • SMITH ET AL. 335
AL and control cells. Cells expressing SEK1-AL were signif-
icantly protected against A -induced cell death compared
with cells transfected with the vector alone. To further con-
firm these results, SH-SY5Y cells treated with SP600125, an
inhibitor of JNK phosphorylation, displayed partially reduced
p66Shc phosphorylation and were protected against A  toxic-
ity (Fig. 5, C and D). These results suggest that JNK is one of
the upstream kinases that phosphorylates p66Shc at Ser36 in
response to A  treatment.
A  induces forkhead phosphorylation
Previous results suggest that p66Shc regulates intracellular oxi-
dant levels and that H2O2 can negatively regulate forkhead ac-
tivity (Nemoto and Finkel, 2002; Trinei et al., 2002). Phos-
phorylation of forkhead proteins results in the inactivation of
forkhead transcriptional activity and the down-regulation of its
target genes such as those encoding ROS-scavenging enzymes
(MnSOD, catalase, etc.; Nemoto and Finkel, 2002). To investi-
gate whether or not A  regulates forkhead phosphorylation, ly-
sates from SH-SY5Y cells and 7 DIV cultures treated with A 
for various times were subjected to Western blot analysis using
antibodies that detect phosphorylated FKHRL1 and FKHR
(Fig. 6). Duplicate blots were probed with antibodies recogniz-
ing FKHR to verify equal protein loading of samples. As
shown in Fig. 6 (A and B), treatment with A  led to increases
in the phosphorylation of FKHRL1 and FKHR in SH-SY5Y
cells and 7 DIV cultures, respectively. Interestingly, FKHR
was also phosphorylated in rat PC12 cells expressing p66Shc
with patterns similar to those of SH-SY5Y cells (Fig. 6 C).
However, A  treatment did not increase the phosphorylation of
forkhead in p66ShcS36A-expressing PC12 cells (Fig. 6 C),
suggesting that A  regulated forkhead phosphorylation in a
p66Shc-dependent manner. We did not detect the phosphoryla-
tion of other FKHs in these cell cultures after A  treatment
(unpublished data). The different phosphorylated isoforms of
FKHs after A  treatment in these cell populations may result
from species differences.
Ebselen blocks A -induced p66Shc and 
forkhead phosphorylation and cell death
We further investigated the findings that A  induced the phos-
phorylation of forkhead in a p66Shc-dependent manner by ex-
amining the effects of ROS scavengers after exposure to A .
Treatment of SH-SY5Y cells with the glutathione peroxidase
mimetic ebselen reduced A -induced intracellular and mito-
Figure 5. Reduction of JNK activation partially blocks A -
induced p66Shc phosphorylation. (A) p66Shc phosphoryla-
tion at Ser36 in SH-SY5Y cells overexpressing either SYV or
SEK1-AL after addition of 30  M A  at various times after a
16-h serum starvation period was detected by Western blot
analysis, sequentially using anti–phospho-p66Shc (Ser36)
and anti-Shc antibodies. The blots are representative of three
separate experiments. (B) Cells were treated with 30  M A 
for 24 h in serum-free media containing N2 supplements. Try-
pan blue exclusion was used to determine cell death. Data
are means   SEM for three separate experiments performed
in duplicate. *, P   0.05 versus untreated cells; #, P   0.05
versus A -treated SYV cells. (C) SH-SY5Y cells were serum-
starved for 16 h and were either left untreated or pretreated
with 20  M SP600125 for 1 h followed by 30- M A 
treatment for 10 and 20 min. Cells were harvested and cell
lysates were subjected to Western blot analysis using anti-
bodies that recognized phospho-FKHR, phospho-Shc (Ser36),
and Shc. The blots are representative of three separate ex-
periments. (D) SH-SY5Y cells were either left untreated or
pretreated with 20  M SP600125 for 1 h, and then treated
with 30  M A  for 24 h. Cell death was measured by Trypan
blue exclusion. *, P   0.05 versus untreated cells; #, P  
0.05 versus A -treated cells.
Figure 6. A  induces forkhead phosphorylation. (A) In SH-SY5Y cells
treated with 30  M A  at various times after a 16-h serum starvation
period, endogenous FKHRL1 phosphorylation was detected by Western
blot analysis using antibodies that recognized phospho-FKHRL1 or FKHR.
(B) In 7 DIV cultures treated with 25  M A  for various lengths of time,
endogenous FKHR and phosphorylated FKHR were detected by Western
blot analysis using antibodies that recognized phospho-FKHR or FKHR,
respectively. The blots are representative of three separate experiments.
(C) Endogenous FKHR phosphorylation in transfected PC12 cells that
ectopically expressed either p66Shc or p66ShcS36A after treatment with
A  was assessed by Western blotting using antibodies that recognized
either phospho-FKHR or FKHR. These experiments were performed at least
three times, yielding the same results.JCB • VOLUME 169 • NUMBER 2 • 2005 336
chondrial ROS production (Fig. 7, C–E), prevented the phos-
phorylation of p66Shc and forkhead FKHRL1 (Fig. 7 B), and
protected against cell death (Fig. 7 A). Similar results were ob-
tained in PC12 cells expressing p66Shc and in 7 DIV cultures
pretreated with the glutathione precursor N-acetylcysteine
(NAC; unpublished data). These findings suggest that ROS
scavengers block A -induced cell death by blocking the phos-
phorylation of p66Shc and FKHs.
Discussion
In this paper, we demonstrate that A  caused cell death and in-
duced p66Shc phosphorylation at serine 36, partially in a JNK-
dependent manner. Cells overexpressing dominant-negative
p66ShcS36A decreased the A -induced levels of intracellular
ROS and were more resistant to A -induced cell death. Fur-
thermore, we demonstrate that A  induced the phosphorylation
(and hence inactivation) of forkhead FKHRL1 and FKHR tran-
scription factors in cells and primary cultures. Cells expressing
p66ShcS36A as well as cells treated with ebselen or NAC ex-
hibited more resistance to A -induced death and reduced fork-
head phosphorylation. These results suggest that phosphoryla-
tion of Ser36 p66Shc and forkhead proteins plays an important
role in A  toxicity.
The accumulation of oxidative cellular damage has been
reported in AD and some other age-related and neurodegenera-
tive diseases, such as Parkinson’s, Huntington’s, and amyo-
trophic lateral sclerosis (Sharp and Ross, 1996; Smith et al.,
1997; Albers and Beal, 2000; Jellinger, 2001). Previous papers
show that A  can directly generate ROS including H2O2
through inherent redox activity, such as that derived from the
complexing of A  with metals (Cu
2  and Zn
2 ; Huang et al.,
1999a,b; Opazo et al., 2002). ROS are freely permeable across
tissue boundaries and accumulate intracellularly. However, the
molecular mechanisms of A  leading to oxidative cell death
have not been fully elucidated. Recently, several groups have
shown that phosphorylation of the p66Shc adaptor protein
plays an important role in signaling events leading to cell death
in response to oxidative damage (Migliaccio et al., 1999; Le et
al., 2001; Nemoto and Finkel, 2002). Here, we show that A 
can induce p66Shc phosphorylation at Ser36 (Fig. 1). Ectopic
expression of p66ShcS36A decreased A -induced intracellular
ROS level and protected against A -induced cell death. More-
over, treatment with antioxidants (ebselen or NAC) decreased
intracellular ROS level, reduced p66Shc phosphorylation,
and protected against A -induced cell death (Fig. 7). These
findings support the notion that A  causes neuronal death
by mechanisms involving oxidative damage and requiring
p66Shc phosphorylation. It has recently been demonstrated that
p66Shc-null mouse fibroblasts have enhanced cellular resis-
tance to treatment with oxidants, UV, and H2O2 (Migliaccio et
al., 1999). Mice lacking p66Shc are less susceptible to oxida-
tive damage induced by paraquat and have an extended life
span (Migliaccio et al., 1999). These findings suggest that
phosphorylation of p66Shc at Ser36 is critical for eliciting cell
death in response to oxidative stress. Therefore, the prevention
of p66Shc phosphorylation may have a therapeutic impact on
AD and other age-related diseases that are associated with oxi-
dative damage.
JNK is a stress-activated protein kinase whose function
has been associated with the induction of apoptosis by several
types of environmental stress and cellular stress (including
H2O2) in neuronal cells (Verheij et al., 1996; Le Niculescu et
al., 1999; Namgung and Xia, 2000). Recently, we demon-
strated that JNK activation was critical for A -induced neu-
ronal death (Wei et al., 2002b). In that paper, overexpression of
a dominant-interfering form of SEK1 (MKK4), the upstream
kinase of JNK, prevented the cell death induced by A  and in-
hibited JNK activation (Wei et al., 2002b). Here, we show that
cells expressing SEK1-AL also reduced p66Shc phosphoryla-
tion at Ser36, suggesting that JNK activation plays a role in
regulating this phosphorylation. We confirmed this possi-
bility by using a chemical inhibitor of JNK, SP600125, which
yielded similar results (Fig. 5). Our findings are also in agree-
Figure 7. Effect of ebselen on p66Shc phosphorylation and A  toxicity.
(A) SH-SY5Y cells were either left untreated or pretreated with 10  M
ebselen for 1.5 h, and then treated with 30  M A  for 24 h, whereupon
cell death was measured by Trypan blue exclusion. *, P   0.05 versus
untreated cells; #, P   0.05 versus A -treated cells. (B) Cells were serum-
starved for 16 h, and then were either left untreated or pretreated with 10  M
ebselen for 1.5 h followed by 30- M A  treatment for the time periods
shown. Cells were harvested and cell lysates were subjected to Western
blot analysis using antibodies that recognized phospho-KHRL1, phospho-
Shc (Ser36), or Shc. The blots are representative of three separate experi-
ments. (C) SH-SY5Y cells were either left untreated or pretreated with 10  M
ebselen for 1.5 h, and then treated with 30  M A  for 4 h. DCF fluores-
cence was quantified in SHSY5Y cells by using a CytoFluor Multi-well
Plate Reader. Data are the means   SEM for three separate experiments
performed in duplicate. *, P   0.05 versus untreated cells; #, P   0.05
versus A -treated vector cells. (D and E) SH-SY5Y cells were either left
untreated or pretreated with 10  M ebselen for 1.5 h, and then treated
with 30  M A  for 12 h. HE and DHR fluorescence were quantified,
respectively. Data are means   SEM for three separate experiments per-
formed in duplicate. #, P   0.05 versus A -treated vector cells.P66SHC/FORKHEAD PROTEINS MEDIATE A  TOXICITY • SMITH ET AL. 337
ment with previous papers showing that JNK is the kinase that
phosphorylates p66Shc at Ser36 in response to UV irradiation
(Le et al., 2001), although we cannot exclude the possibility
that additional kinases may also phosphorylate p66Shc. Several
groups have shown that JNK is activated in degenerating or ap-
optotic neurons in AD brains (Anderson et al., 1995, 1996;
Marcus et al., 1998; Shoji et al., 2000; Zhu et al., 2001). To-
gether, these findings suggest that p66Shc, like c-Jun, is a sub-
strate of JNK during the induction neuronal loss in AD by oxi-
dative damage. However, further studies using AD transgenic
mice or AD brain tissue are needed to definitively link the
JNK–p66Shc pathway with AD pathogenesis in vivo.
Genetic determinants of longevity include the forkhead-
related transcription factor DAF-16 in C. elegans and the
p66SHC locus in mice (Lin et al., 1997; Migliaccio et al.,
1999). Previous papers have demonstrated that p66Shc regu-
lates intracellular oxidant levels in mammalian cells and that
H2O2 can negatively regulate forkhead activity (Nemoto and
Finkel, 2002; Trinei et al., 2002). Expression of FKHRL1 re-
sults in an increase in both ROS-scavenging activity and oxi-
dative stress resistance (Nemoto and Finkel, 2002). In agree-
ment with this previous literature, we show here that A 
treatment was capable of inducing the phosphorylation of
forkhead FKHRL1 and FKHR transcription factors in cells
and primary cultures. Cells expressing p66ShcS36A as well
as cells treated with ebselen or NAC exhibited more resis-
tance to A -induced death and reduced forkhead phosphory-
lation. Previous studies have shown that phosphorylation of
FKHs results in their cytoplasmic retention and inactivation,
thereby inhibiting the expression of FKH-regulated genes,
which control the cell cycle, cell death, cell metabolism, and
oxidative stress (Brunet et al., 2001; Burgering and Kops,
2002). This pathway appears to be well conserved throughout
evolution from C. elegans to higher eukaryotes (Biggs et al.,
1999; Brunet et al., 1999; Kops et al., 1999; Tran et al.,
2002). Whereas nonphosphorylated FKHs are localized in the
nucleus and activate gene transcription, phosphorylation of
FKHs induces their relocalization from the nucleus to the cy-
toplasm (and hence away from the promoters of target genes)
and consequently inhibits their ability to induce the expres-
sion of target genes such as MnSOD (Biggs et al., 1999; Bru-
net et al., 1999; Nakamura et al., 2000; Dijkers et al.,
2000a,b; Kops et al., 2002; Tran et al., 2002). These FKH
regulatory events likely represent one of the mechanisms
underlying A  toxicity. Interestingly, in cells expressing
p66ShcS36A, phosphorylation of FKHR was diminished,
suggesting that p66Shc phosphorylation may be required for
A -induced FKH phosphorylation leading to a subsequent
down-regulation of target genes such as MnSOD and ensuing
cell death. These findings further suggest that p66Shc may
function by regulating an intracellular ROS/redox system,
which, in turn, modulates forkhead activity. Together with
previous papers, we propose that A  toxicity is elicited
through the generation of ROS leading to the activation of the
JNK pathway, which in turn activates p66Shc by phosphory-
lation at Ser36. Activated p66Shc then triggers the phosphor-
ylation of FKH, thereby down-regulating target genes such as
MnSOD and leading to an even greater accumulation of cellu-
lar ROS. This biochemical cycle causes cell death. In sum-
mary, our findings not only advance our understanding of the
intricacies of neuronal loss in AD but also suggest that JNK,
p66Shc, and FKHs may be useful as potential therapeutic tar-
gets in the treatment of AD and other age-related disorders.
Materials and methods
Materials
Media, N2, and N27 supplements for cell culture were obtained from In-
vitrogen. A  25-35 and A  35-25 (Biosource International) were dis-
solved in water and incubated at 37 C for 24 h before use. Hoechst
33342, DCFDA, HE, and DHR were obtained from Molecular Probes.
Anti-Shc antibody was purchased from BD Biosciences; anti-FKHR, anti–
phospho-FKHR, and anti–phospho-FKHRL1 were purchased from Cell Sig-
naling Technology. Anti–phospho-p66Shc (Ser36) antibody was pur-
chased from Calbiochem. PP2A1, NAC, and ebselen were obtained
from Sigma-Aldrich. SP600125 was obtained from BIOMOL Research
Laboratories, Inc.
Neuronal cultures
Mouse primary cortical neuronal cultures were derived from a CD-1 out-
breed mouse (The Jackson Laboratory) at embryonic 15 to 16. Cortices
were dissociated as described previously (Movsesyan et al., 2004); after
dissociation, neurons were plated on laminin- and poly-D-lysine–coated
plates (BD Biosciences) and cultured in neurobasal medium with the addi-
tion of glutamax, B-27 supplement, and penicillin/streptomycin. Under
these culture conditions, 95% of cells were neurons. At 7 DIV the neuronal
cultures were treated with A .
Cell culture and transfection
SH-SY5Y human neuroblastoma cells were grown in DME with 10% FBS,
1  nonessential amino acid, and 1  antibiotic-antimycotic (100 U/ml
penicillin, 100  g/ml streptomycin, and 2.5  g/ml fungizone) solutions
at 37 C in 5% CO2/95% air. Transfections were performed with Lipo-
fectAmine (Invitrogen) according to the manufacturer’s protocol. SH-SY5Y
cells were transfected with either pcDNA3.zeo or pcDNA.zeo-SEK1-AL
constructs (provided by J.R. Woodgett, The Princess Margaret Hospital,
Toronto, Canada). SEK1-AL encodes a dominant-negative form of SEK1
containing a double mutation (S220A and T224L). Pooled cells stably ex-
pressing pcDNA3.zeo or pcDNA.zeo-SEK1-AL were selected in media
containing 200  g/ml Zeocin (Invitrogen) for 2 mo (Wei et al., 2002b).
PC12 cells were grown in DME with 10% FCS. Stable PC12 cell lines ex-
pressing human wild-type p66Shc and dominant-negative p66Shc were
obtained by transfection and subsequent isolation by limiting dilutions in
G418 (Nemoto and Finkel, 2002).
Measurement of cell death and viability
Trypan blue exclusion was used to measure cell death by counting the
number of dead (blue) and live cells in the cultures after A  peptide treat-
ment. Hoechst labeling of cells to detect apoptotic nuclei was performed
as described previously (Dive et al., 1992; Wei et al., 2002a). In brief,
cells were fixed with 4% PFA for 30 min at RT and incubated in a solution
containing Hoechst 33342 and propidium iodine for 30 min, after which
they were examined by fluorescence microscopy. Apoptotic cells were
identified as those exhibiting condensed and fragmented nuclei. The per-
centage of apoptotic cells was calculated as the ratio of apoptotic cells to
total cells. A minimum of 400 cells was counted for each treatment.
SH-SY5Y cell viability assay. Cells were cotransfected with
pcDNA3.1-GFP along with vector pcDNA3.1-xpress, pcDNA3.1-xpress-
p66Shc, or pcDNA3.1-xpress-p66ShcS36A at a 1:10 ratio for 24 h in
10% FBS DME media, and then changed to 2% FBS DME media and
treated with A  for 24 h. GFP-positive cells were counted by using fluores-
cence microscopy. A minimum of 1,000 cells were counted in each treat-
ment group. The percentage of GFP-positive cells relative to the total num-
ber of cells in six random fields was calculated.
Measurement of cellular caspase-3 activity
Cells were harvested in cell lysis buffer (50  M Hepes, pH 7.4, 1 mM
EDTA, 0.1% CHAPS, and 0.1% Triton X-100). DEVD-p-nitroanilide was
the substrate for caspase-3. The experiments were performed according to
the manufacturer’s protocol (Biosource International).JCB • VOLUME 169 • NUMBER 2 • 2005 338
Measurements of intracellular ROS, superoxide level, and mitochondrial 
ROS
The levels of cytosolic ROS were measured by DCFDA (Molecular Probes)
as previously described (Nemoto and Finkel, 2002; Sponne et al., 2003).
In brief, cells were treated with 30  M A  25-35 at 37 C for 4 h, washed
with PBS, and incubated for 45 min with DCFDA, which is initially nonfluo-
rescent and is converted by oxidation to the fluorescent molecular DCF.
DCF was quantified using a CytoFluor Multi-well Plate Reader (Series 400;
PerSeptive Biosystems) with 485-nm excitation and 538-nm emission filters;
fluorescence intensity of cells was quantified using confocal microscopy
and the METAMORPH image analysis software. The levels of intracellular
superoxide anion radical were measured with HE, which is oxidized to flu-
orescent ethidium cation by superoxide, by using methods similar to those
described previously (Q. Guo et al., 1999). In brief, cells were incubated
for 30 min in the presence of 5  M HE (Molecular Probes) and washed
twice with Locke’s solution, whereupon confocal images of cell-associated
ethidium fluorescence were acquired (488-nm excitation and 590-nm emis-
sion). The average pixel intensity in individual cell bodies was determined
with METAMORPH image analysis software. DHR was used to quantify rel-
ative levels of mitochondrial peroxynitrite by using methods similar to those
described previously (Q. Guo et al., 1999). DHR localizes to mitochondria
and fluoresces when oxidized to the positively charged rhodamine 123 de-
rivative. In brief, cells were incubated for 30 min in the presence of 5  M
DHR and washed three times with Locke’s solution, and confocal images of
cellular fluorescence were acquired (488-nm excitation and 510-nm emis-
sion) and analyzed as described for DCF fluorescence.
Immunoblot and PP2A1 treatment
Cells were harvested in lysis buffer (20 mM Hepes, pH 7.4, 2 mM EGTA,
50 mM  -glycerophosphate, 1% Triton X-100, 10% glycerol, 1 mM dithio-
threitol, 1 mM PMSF, 10  g/ml leupeptin, 10  g/ml aprotinin, 1 mM
Na3VO4, and 5 mM NaF). Where indicated, cell lysates (0.1 mg of pro-
tein) were treated with PP2A1 for 30 min at 30 C as described previously
(Yang and Horwitz, 2000). The reaction was stopped by adding sample
buffer and boiling. Lysates were resolved on 4–12% NuPAGE Bis-Tris gels
(30   g/lane) and transferred to polyvinylidene difluoride membranes
(Millipore). The membranes were blocked in TBST (10 mM Tris-HCl, pH
7.4, 150 mM NaCl, and 0.1% Tween 20) containing 5% nonfat milk and
probed with different antibodies. Proteins were detected by using ECL re-
agents (NEN Life Science Products).
Data analysis
Quantitative data are expressed as arithmetic means   SEM based on at
least three separate experiments performed in duplicate. The difference be-
tween two groups was statistically analyzed by t test or an analysis of vari-
ance (one-way ANOVA). A P value  0.05 was considered significant.
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